Dr. Kevin Vincent De Regnier, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 W. Hutchings St., Winterset, IA 50273 Phone: 515-462-2950 Fax: 515-462-4371 |
Regina Barnett, NP Family Medicine Medicare: Medicare Enrolled Practice Location: 60 E Court Ave, Winterset, IA 50273 Phone: 515-462-1162 |
Dr. Joseph M. Kimball, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 W Hutchings St, Winterset, IA 50273 Phone: 515-462-2950 Fax: 515-462-4371 |
Dr. Sherri D. Broadbent, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 300 W Hutchings St, Winterset, IA 50273 Phone: 515-462-2950 Fax: 515-462-4371 |
News Archive
Chiasma, Inc., a privately held biopharma company, announced that the Food and Drug Administration has granted orphan drug designation for Chiasma's investigational new drug, Octreolin, an oral form of octreotide acetate that uses the Company's proprietary Transient Permeability Enhancer technology for the oral treatment of acromegaly, a hormonal disorder that results from an excess of growth hormone.
A surgically implanted neuroprosthesis—programmed to stimulate coordinated activity of hip, knee, and ankle muscles—has led to substantial improvement in walking speed and distance in a patient with limited mobility after a stroke, according to a single-patient study in the American Journal of Physical Medicine & Rehabilitation, the official journal of the Association of Academic Physiatrists.
HealthyLifeNetwork.com is officially online and making its healthful presence known on the world-wide web. The new site has been in development for sometime but overall the time to market from concept to publish was fast-tracked by a Chicago-based team of writers, editors, designers and marketing wizards.
A social media post, which in April was shared widely on Facebook and made appearances on a conservative online discussion forum, asserts that former President Barack Obama signed legislation that caused companies to manufacture medical devices overseas, including items essential for the current coronavirus pandemic.
Amid the worsening Ebola outbreak in the Congo, now threatening to spill into Rwanda, a new study suggests that an existing, FDA-approved drug called nitazoxanide could potentially help contain this deadly, highly contagious infection.
› Verified 1 days ago